Eli Lilly and Company News
Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact
Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.
Cramer's Mad Money Recap 6/15: Powell Crushes it
Jim Cramer says the Fed action is great news for high-growth tech stocks, which should be among the first sectors to recover.
Cramer's Mad Money Recap 6/7: Target, Smucker, Eli Lilly
Jim Cramer says smart investing is as simple as buying growth stocks when interest rates begin to fall.
Stock Market Today - 6/6: Dow Ends Slightly Higher as Treasury Yields Top 3%; Amazon Gains After 20-for-1 Split
Solid jobs and manufacturing data are prompting bets on a so-called 'Goldilocks' outcome for U.S. stocks as the Fed looks to tame inflation without choking-off growth.
Eli Lilly Stock Gains On Impressive Data From Jardiance Diabetes Drug Trial
"These five-year results ... showing empagliflozin was associated with a decreased risk of hospitalization for heart failure and for death, are encouraging data for adults with type 2 diabetes," said co-lead investigator Dr. Elisabetta Patorno.
Breaking News
Disney Mobile Game Opens Up a New Universe
Familiar Disney characters populate an alternate reality in new interactive game.
Birth Control Stocks May Benefit From the Reversal of Roe v. Wade
The historic Supreme Court decision may force women to make different choices.
Something Strange is Happening With Home Prices
As mortgage rates hit fresh highs, there's something unusual going on with the real estate market.
Roe Decision Forces Disney, Netflix to Take a Political Stand
Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.